Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: Targeting the renin-angiotensin system

Experimental Physiology

Volumn 99, Issue 4, 2014, Pages 627-631

  Sabharwal, Rasna ^a   Chapleau, Mark W ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN[1-7]; CYTOKINE; DELTA SARCOGLYCAN; LOSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN I (1-7); PEPTIDE FRAGMENT; SARCOGLYCAN;

ANIMAL TISSUE; ARTICLE; AUTONOMIC DYSFUNCTION; CONGESTIVE CARDIOMYOPATHY; DRUG INFUSION; HEART ARRHYTHMIA; HEART DISEASE; HISTOPATHOLOGY; LOCOMOTION; MORTALITY; MUSCULAR DYSTROPHY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSORY NERVE; SKELETAL MUSCLE; ANIMAL; AUTONOMIC NERVOUS SYSTEM; CARDIOMYOPATHIES; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; GENOTYPE; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HUMAN; INNERVATION; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE;

ANGIOTENSIN I; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AUTONOMIC NERVOUS SYSTEM; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; GENOTYPE; HEART; HUMANS; MICE, KNOCKOUT; MOTOR ACTIVITY; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MYOCARDIUM; PEPTIDE FRAGMENTS; PHENOTYPE; RENIN-ANGIOTENSIN SYSTEM; SARCOGLYCANS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84897463082     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.074336     Document Type: Article

References (32)

1. Allikian MJ & McNally EM (2007). Processing and assembly of the dystrophin glycoprotein complex. Traffic 8, 177-183.
2. Barton ER (2006). Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle. Am J Physiol Cell Physiol 290, C411-C419.
3. Blain A, Greally E, Laval S, Blamire A, Straub V & MacGowan GA (2013). Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy. PLoS One 8, e57260.
4. Bushby K, Lochmüller H, Lynn S & Straub V (2009). Interventions for muscular dystrophy: molecular medicines entering the clinic. Lancet 374, 1849-1856.
5. Cabello-Verrugio C, Morales MG, Cabrera D, Vio CP & Brandan E (2012). Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles. J Cell Mol Med 16, 752-764.
6. Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW & Dietz HC (2007). Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13, 204-210.
7. Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M & Santarone M (2002). Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89, 838-841.
8. Cozzoli A, Nico B, Sblendorio VT, Capogrosso RF, Dinardo MM, Longo V, Gagliardi S, Montagnani M & De Luca A (2011). Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice. Pharmacol Res 64, 482-492.
9. Diz DI, Kasper SO, Sakima A & Ferrario CM (2007). Aging and the brain renin-angiotensin system: insights from studies in transgenic rats. Cleve Clin J Med 74 Suppl 1, S95-S98.
10. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G & Bécane HM (2005). Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 45, 855-857.
11. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R & Campbell KP (1998). Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol 142, 1461-1471.
12. Ervasti JM & Campbell KP (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122, 809-823.
13. Fanin M, Duggan DJ, Mostacciuolo ML, Martinello F, Freda MP, Soraru G, Trevisan CP, Hoffman EP & Angelini C (1997). Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet 34, 973-977.
14. Felder RB, Francis J, Zhang ZH, Wei SG, Weiss RM & Johnson AK (2003). Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 284, R259-R276.
15. Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ & Raizada MK (2010). Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55, 207-213.
16. Guggilam A, Patel KP, Haque M, Ebenezer PJ, Kapusta DR & Francis J (2008). Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail 10, 625-634.
17. Kudo H, Kai H, Kajimoto H, Koga M, Takayama N, Mori T, Ikeda A, Yasuoka S, Anegawa T, Mifune H, Kato S, Hirooka Y & Imaizumi T (2009). Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension 54, 832-838.
18. Matsusaka T & Ichikawa I (1997). Biological functions of angiotensin and its receptors. Annu Rev Physiol 59, 395-412.
19. O'Callaghan EL, Choong Y-T, Jancovski N & Allen AM (2013). Central angiotensinergic mechanisms associated with hypertension. Auton Neurosci 175, 85-92.
20. Piepoli MF & Crisafulli A (2014). Pathophysiology of human heart failure: importance of skeletal muscle myopathy and reflexes. Exp Physiol 99, 609-615.
21. Politano L, Palladino A, Nigro G, Scutifero M & Cozza V (2008). Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies. Acta Myol 27, 114-122.
22. Ramaswamy KS, Palmer ML, van der Meulen JH, Renoux A, Kostrominova TY, Michele DE & Faulkner JA (2011). Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. J Physiol 589, 1195-1208.
23. Rosas-Ballina M & Tracey KJ (2009). Cholinergic control of inflammation. J Intern Med 265, 663-679.
24. Sabharwal R & Chapleau MW (2012). Angiotensin-[1-7] infusion reduces skeletal muscle fibrosis and restores locomotor activity and sympathovagal balance in a mouse model of muscular dystrophy. Hypertension 60, A398.
25. Sabharwal R, Weiss RM & Chapleau MW (2009). Dysautonomia precedes cardiomyopathy in a mouse model of muscular dystrophy. Auton Neurosci 149, 89-90.
26. Sabharwal R, Weiss RM, Zimmerman K & Chapleau MW (2010). Angiotensin II contributes to skeletal muscle fibrosis, reduced locomotor activity and autonomic dysfunction in δ-sarcoglycan deficient mice with muscular dystrophy. Hypertension 56, E103.
27. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, Thomas GD & Victor RG (2000). Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 97, 13818-13823.
28. Santos RA, Ferreira AJ & Simoes ESAC (2008). Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 93, 519-527.
29. Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva RA, Diez-Freire C, Dooies A, Jun JY, Sriramula S, Mariappan N, Pourang D, Venugopal CS, Francis J, Reudelhuber T, Santos RA, Patel JM, Raizada MK & Katovich MJ (2010). The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 182, 1065-1072.
30. Sun G, Haginoya K, Dai H, Chiba Y, Uematsu M, Hino-Fukuyo N, Onuma A, Iinuma K & Tsuchiya S (2009). Intramuscular renin-angiotensin system is activated in human muscular dystrophy. J Neurol Sci 280, 40-48.
31. 1 receptors in heart failure. Am J Physiol Heart Circ Physiol 295, H1216-H1226.
32. Zucker IH, Schultz HD, Li YF, Wang Y, Wang W & Patel KP (2004). The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol 84, 217-232.